Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance

Stock Information for Equillium Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Equillium Inc.

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference
EQ Inc. Reports Second Quarter Financial Results
Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights
Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
Equillium to Participate in Upcoming Investor Conferences
Equillium to be included in the Russell Microcap® Index

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.